Experience

Active Biotech AB
• Biotechnology
• 1 - 100 Employee
• VP Non-clincal R&D

  • Jan 2022 - Present
• Director Preclinical Development

  • Sep 2018 - Sep 2018

• Director of Preclinical Development

  • Sep 2018 - Sep 2018

• Head of Pharmacology

  • Sep 2008 - Sep 2018

  Manages a team of scientists and technicians performing in vivo studies for PK evaluation, PK/PD models, disease models for cancer and autoimmunity, as well as dose finding studies before pivotal toxicology studies. Histological and immunohistochemical lead. Representing ActiveBiotech AB and six other companies that rent lab space at AB, towards Swedish Agricultural Board.Provides pharmacological, tox/safety and histological expertize to several projects.

• Scientist

  • Sep 2002 - Sep 2008

  Histological and immunohistochemical lead.Planned and led in vivo studies in PK/PD and disease models for cancer and autoimmunity as well as dose finding studies before pivotal tox and safety studies.

• Scientist, Group Leader

  • Jun 2001 - Jan 2002

  Managed a team of scientists and technicians providing in vivo and in vivo/ex vivo studies supporting several projects. Planned and led in vivo studies in PK/PD and disease models for cancer and autoimmunity as well as dose finding studies before pivotal tox and safety studies Managed a team of scientists and technicians providing in vivo and in vivo/ex vivo studies supporting several projects. Planned and led in vivo studies in PK/PD and disease models for cancer and autoimmunity as well as dose finding studies before pivotal tox and safety studies



Lund Universty

• Sweden
• Higher Education
• 300 - 400 Employee

• Wallenberg Retina Center

  • Feb 2000 - Jun 2001

  Characterization of retinal development in culture, using PCR and immunohistochemistry on retinal explants from rats. The studies on explanted retinas were concentrated on developmental and differentiation events of different cell subtypes Published three papers and presented three posters Characterization of retinal development in culture, using PCR and immunohistochemistry on retinal explants from rats. The studies on explanted retinas were concentrated on developmental and differentiation events of different cell subtypes Published three papers and presented three posters



AstraZeneca

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Research Scientist

  • Dec 1998 - Jan 2000

  Histological and immunohistochemical lead on an inflammation pharmacology team. Planned and led in vivo studies in inflammation models supporting several projects. Histological and immunohistochemical lead on an inflammation pharmacology team. Planned and led in vivo studies in inflammation models supporting several projects.